Literature DB >> 10602516

Induction of apoptosis by SLK, a Ste20-related kinase.

L A Sabourin1, M A Rudnicki.   

Abstract

We have cloned and characterized a novel murine Ste20-related kinase designated SLK. SLK displays high homology to the Ste20-related kinase LOK, and is more distantly related to MST1 and 2, both Ste20-like kinases. In addition, SLK displays high homology to microtubule and nuclear associated protein (M-NAP) and AT1-46, both of unknown function. SLK is ubiquitously expressed as multiple mRNAs in tissues and cell lines and is downregulated by mitogen depletion in differentiating myoblasts. Biochemical characterization showed that SLK overexpression activates c-Jun amino-terminal kinase 1 (JNK1). However, in vitro kinase assays indicated that SLK was not activated in response to various growth factors or stress-inducing agents. Immunofluorescence studies revealed that SLK colocalized to distinct cytosolic domains, preferentially at the periphery of the cells. In addition, prolonged overexpression of SLK in cultured fibroblasts resulted in apoptosis as demonstrated by annexin-V and TUNEL staining. Our results suggest that SLK belongs to a new family of protein kinases, mediating activation of the stress response pathway through a novel signaling cascade.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602516     DOI: 10.1038/sj.onc.1203119

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  Focal adhesion kinase inhibitors are potent anti-angiogenic agents.

Authors:  Miguel A Cabrita; Laura M Jones; Jennifer L Quizi; Luc A Sabourin; Bruce C McKay; Christina L Addison
Journal:  Mol Oncol       Date:  2011-10-20       Impact factor: 6.603

Review 2.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

Review 3.  A novel role for the Ste20 kinase SLK in adhesion signaling and cell migration.

Authors:  Simona M Wagner; Luc A Sabourin
Journal:  Cell Adh Migr       Date:  2009-04-21       Impact factor: 3.405

4.  Ste20-like kinase, SLK, a novel mediator of podocyte integrity.

Authors:  Andrey V Cybulsky; Joan Papillon; Julie Guillemette; Natalya Belkina; Genaro Patino-Lopez; Elena Torban
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-29

5.  Regulation of Catalytic and Non-catalytic Functions of the Drosophila Ste20 Kinase Slik by Activation Segment Phosphorylation.

Authors:  Vincent Panneton; Apurba Nath; Fadi Sader; Nathalie Delaunay; Ariane Pelletier; Dominic Maier; Karen Oh; David R Hipfner
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

6.  Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination.

Authors:  Bridgid E Hast; Erica W Cloer; Dennis Goldfarb; Heng Li; Priscila F Siesser; Feng Yan; Vonn Walter; Ning Zheng; D Neil Hayes; Michael B Major
Journal:  Cancer Res       Date:  2013-12-09       Impact factor: 12.701

Review 7.  Ste20-related proline/alanine-rich kinase: a novel regulator of intestinal inflammation.

Authors:  Yutao Yan; Didier Merlin
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

8.  Ste20-related protein kinase LOSK (SLK) controls microtubule radial array in interphase.

Authors:  Anton V Burakov; Olga N Zhapparova; Olga V Kovalenko; Liudmila A Zinovkina; Ekaterina S Potekhina; Nina A Shanina; Dieter G Weiss; Sergei A Kuznetsov; Elena S Nadezhdina
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

9.  Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities.

Authors:  Amandine Bemmo; Christel Dias; April A N Rose; Caterina Russo; Peter Siegel; Jacek Majewski
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

10.  The germinal center kinase GCK-1 is a negative regulator of MAP kinase activation and apoptosis in the C. elegans germline.

Authors:  Katherine R Schouest; Yasuhiro Kurasawa; Tokiko Furuta; Naoki Hisamoto; Kunihiro Matsumoto; Jill M Schumacher
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.